top of page


Cat. No.: ISPL-0248

For research use only. We do not sell to patients.



Size                                                         Price                                                Stock

10mM (in 1mL DMSO)                          510 USD Price               

05 mg                                                    452 USD Price               

25 mg                                                    1356 USD Price               

50 mg                                                    2520 USD Price               


Biological activity


CQ31, a small molecule, selectively activates caspase activation and recruitment domain-containing 8 (CARD8).

To view more products

In Vivo

CQ31 inhibitor is a small molecule that selectively activates the CARD8 inflammasome. This makes it a potential therapeutic agent for a variety of diseases, including inflammatory diseases, cancer, and neurodegenerative diseases.

Inflammatory diseases are caused by an overactive immune system. The CARD8 inflammasome plays a role in the immune response, and CQ31 inhibitor could be used to dampen the immune response and reduce inflammation.

Cancer is a disease in which cells grow uncontrollably. The CARD8 inflammasome can be activated by cancer cells, and CQ31 inhibitor could be used to kill cancer cells.

Neurodegenerative diseases are diseases that damage the nervous system. The CARD8 inflammasome can be activated by damaged neurons, and CQ31 inhibitor could be used to protect neurons from damage.

To view more products

In Vitro

CQ31 inhibitor can also be used in vitro to study the role of the CARD8 inflammasome in various diseases. For example, a CQ31 inhibitor can be used to study how the CARD8 inflammasome is activated in cancer cells.

CQ31 inhibitors can also be used to screen for new drugs that target the CARD8 inflammasome. This could lead to the development of new therapies for a variety of diseases.

Overall, the CQ31 inhibitor is a promising new drug that has the potential to treat a variety of diseases. Further research is needed to determine the safety and efficacy of CQ31 inhibitor in humans.

To view more products

Molecular Weight


To view more products

Molecular Formula


To view more products



To view more products



To view more products


White or off-white

To view more products


Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

To view more products


3 years   -20°C

To view more products

Research update


To view more products

M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome

Nat Chem Biol 2022 May;18(5):565-574.PMID:35165443DOI:10.1038/s41589-021-00964-7.

Inflammasomes are multiprotein complexes that sense intracellular danger signals and induce pyroptosis. CARD8 and NLRP1 are related inflammasomes that are repressed by the enzymatic activities and protein structures of the dipeptidyl peptidases 8 and 9 (DPP8/9). Potent DPP8/9 inhibitors such as Val-boroPro (VbP) activate both NLRP1 and CARD8, but chemical probes that selectively activate only one have not been identified. Here we report a small molecule called CQ31 that selectively activates CARD8. CQ31 inhibits the M24B aminopeptidases prolidase (PEPD) and Xaa-Pro aminopeptidase 1 (XPNPEP1), leading to the accumulation of proline-containing peptides that inhibit DPP8/9 and thereby activate CARD8. NLRP1 is distinct from CARD8 in that it directly contacts DPP8/9's active site; these proline-containing peptides, unlike VbP, do not disrupt this repressive interaction and thus do not activate NLRP1. We expect that CQ31 will now become a valuable tool to study CARD8 biology.

Optimized M24B Aminopeptidase Inhibitors for CARD8 Inflammasome Activation

J Med Chem 2023 Feb 23;66(4):2589-2607.PMID:PMC10149104DOI:10.1021/acs.jmedchem.2c01535.

Inflammasomes are innate immune signaling platforms that trigger pyroptotic cell death. NLRP1 and CARD8 are related human inflammasomes that detect similar danger signals, but NLRP1 has a higher activation threshold and triggers a more inflammatory form of pyroptosis. Both sense the accumulation of intracellular peptides with Xaa-Pro N-termini, but Xaa-Pro peptides on their own without a second danger signal only activate the CARD8 inflammasome. We recently reported that a dual inhibitor of the Xaa-Pro-cleaving M24B aminopeptidases PEPD and XPNPEP1 called CQ31 selectively activates the CARD8 inflammasome by inducing the build-up of Xaa-Pro peptides. Here, we performed structure-activity relationship studies on CQ31 to develop the optimized dual PEPD/XPNPEP1 inhibitor CQ80 that more effectively induces CARD8 inflammasome activation. We anticipate that CQ80 will become a valuable tool to study the basic biology and therapeutic potential of selective CARD8 inflammasome activation.

High-level expression and enzymatic properties of a novel thermostable xylanase with high arabinoxylan degradation ability from Chaetomium sp. suitable for beer mashing

Int J Biol Macromol 2021 Jan 31;168:223-232.PMID:33309660DOI:10.1016/j.ijbiomac.2020.12.040.

A novel thermostable xylanase gene from Chaetomium sp. CQ31 was cloned and codon-optimized (CsXynBop). The deduced protein sequence of the gene shared the highest similarity of 75% with the glycoside hydrolase (GH) family 10 xylanase from Achaetomium sp. Xz-8. CsXynBop was over-expressed in Pichia pastoris GS115 by high-cell density fermentation, with the highest xylanase yield of 10,017 U/mL. The recombinant xylanase (CsXynBop) was purified to homogeneity and biochemically characterized. CsXynBop was optimally active at pH 6.5 and 85 °C, respectively, and stable over a broad pH range of 5.0-9.5 and up to 60 °C. The enzyme exhibited strict substrate specificity towards oat-spelt xylan (2, 489 U/mg), beechwood xylan (1522 U/mg), birchwood xylan (1067 U/mg), and showed relatively high activity towards arabinoxylan (1208 U/mg), but exhibited no activity on other tested polysaccharides. CsXynBop hydrolyzed different xylans to yield mainly xylooligosaccharides (XOSs) with degree of polymerization (DP) 2-5. The application of CsXynBop (200 U/g malt) in malt mashing substantially decreased the filtration time and viscosity of malt by 42.3% and 8.6%, respectively. These excellent characteristics of CsXynBop may make it a good candidate in beer industry.

Structural and biochemical insights into the substrate-binding mechanism of a glycoside hydrolase family 12 β-1,3-1,4-glucanase from Chaetomium sp

J Struct Biol 2021 Sep;213(3):107774.PMID:34329700DOI:10.1016/j.jsb.2021.107774.

β-1,3-1,4-Glucanases are a type of hydrolytic enzymes capable of catalyzing the strict cleavage of β-1,4 glycosidic bonds adjacent to β-1,3 linkages in β-D-glucans and have exhibited great potential in food and feed industrials. In this study, a novel glycoside hydrolase (GH) family 12 β-1,3-1,4-glucanase (CtGlu12A) from the thermophilic fungus Chaetomium sp. CQ31 was identified and biochemically characterized. CtGlu12A was most active at pH 7.5 and 65 °C, respectively, and exhibited a high specific activity of 999.9 U mg-1 towards lichenin. It maintained more than 80% of its initial activity in a wide pH range of 5.0-11.0, and up to 60 °C after incubation at 55 °C for 60 min. Moreover, the crystal structures of CtGlu12A with gentiobiose and tetrasccharide were resolved. CtGlu12A had a β-jellyroll fold, and performed retaining mechanism with two glutamic acids severing as the catalytic residues. In the complex structure, cellobiose molecule showed two binding modes, occupying subsites -2 to -1 and subsites + 1 to + 2, respectively. The concave cleft made mixed β-1,3-1,4-glucan substrates maintain a bent conformation to fit into the active site. Overall, this study is not only helpful for the understanding of the substrate-binding model and catalytic mechanism of GH 12 β-1,3-1,4-glucanases, but also provides a basis for further enzymatic engineering of β-1,3-1,4-glucanases.

High level expression of a novel β-mannanase from Chaetomium sp. exhibiting efficient mannan hydrolysis

Carbohydr Polym 2012 Jan 4;87(1):480-490.PMID:34662993DOI:10.1016/j.carbpol.2011.08.008.

A novel β-mannanase gene (CsMan5A) was cloned from Chaetomium sp. CQ31 and expressed in Pichia pastoris. It had an open reading frame of 1251bp encoding 416 amino acids and contained two introns. The deduced amino acid sequence shared the highest similarity (73%) with the β-mannanase from Emericella nidulans and belongs to glycosyl hydrolase family 5. The recombinant β-mannanase (CsMan5A) was secreted at extremely high levels of 50,030UmL-1 and 6.1mgmL-1 in high cell density fermentor. The purified enzyme was optimally active at pH 5.0 and 65°C and displayed broad pH stability (pH 5.0-11.0) and exhibited specificity towards locust bean gum (Km=3.1mgmL-1), guar gum (Km=9.3mgmL-1) and konjac powder (Km=10.5mgmL-1). It efficiently degraded mannan polysaccharides into mannose and mannooligosacccharides, and also hydrolyzed mannotriose and mannotetraose. These properties make CsMan5A highly useful in food, feed and paper/pulp industries.

Tags: buy CQ31 | CQ31 supplier | purchase CQ31 | CQ31 cost | CQ31 price | CQ31 manufacturer | order CQ31 | CQ31 distributor I HIV activator

Biochemical reagents

CL-097, TLR7/8 Agonist - Imidazoquinoline compound. Highly water-soluble derivative of the imidazoquinoline compound R848 (Resiquimod)

CAT. NO:     ISPL0247

CAS. NO:    1026249-18-2

PURITY:       98.0%


            $ 500 to $ 2900

Fluorescent reagents

Monobromobimane(mBBr) is a thiol-reactive fluorogenic probe. They are widely used in studies involving protein folding, redox signaling, and protein-protein interactions.

CAT. NO:     ISPL0248

CAS. NO:    71418-44-5

PURITY:       98.0%


            $ 250 to $ 920

Proteolysis Targeting Chimera Research Reagents(PROTACs)

CAT. NO:     ISPL-PEC023

CAS. NO:    19171-19-8

PURITY:       98.0%


            $ 60 to $ 490

Pomalidomide, the third-generation immunomodulatory agent acts as a molecular glue, Pomalidomide interacts with the E3 ligase cereblon and induces degradation 

bottom of page